We previously reported that maleimide-functionalized closo-dodecaborate albumin conjugate (MID-AC) with albumin as the drug delivery system is an effective boron carrier for the F98 glioma-bearing rat brain tumor model. The gene discussed is ALB; the disease is central nervous system cancer.